The Food and Drug Administration approved Novo Nordisk’s popular weight-loss drug Wegovy to treat a form of liver disease. Shares climbed roughly 4.5% in Denmark (read more about [weight-loss drugs’ s …
Stocks to Watch Monday: Novo Nordisk, Soho House, UnitedHealth, Palo Alto
view original post